Atlas Trials

A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)

Clinical trial NCT07568236 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07568236
Sponsor
Chinese University of Hong Kong
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Vasomotor SymptomsProstate Cancer
Start date
2026-07-01
Primary completion
2027-12-31
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.